Schmitt, Volker H.
Prochaska, Jürgen H.
Föll, Annegret S.
Schulz, Andreas
Keller, Karsten
Hahad, Omar
Koeck, Thomas
Tröbs, Sven-Oliver
Rapp, Steffen
Beutel, Manfred
Pfeiffer, Norbert
Strauch, Konstantin
Lackner, Karl J.
Münzel, Thomas
Wild, Philipp S.
Funding for this research was provided by:
Bundesministerium für Bildung, Wissenschaft und Forschung (BMBF 01EO1503)
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Article History
Received: 14 May 2021
Accepted: 2 September 2021
First Online: 24 September 2021
Competing interests
: J.H.P. received funding for lecturing by Bayer AG and Boehringer Ingelheim outside the topic of this work. P.S.W. reports the submitted work Grants from Bayer AG, non-financial grants from Philips Medical Systems, grants and consulting fees from Boehringer Ingelheim, Grants and consulting fees from Novartis Pharma, Grants and consulting fees from Sanofi-Aventis, Grants, consulting and lecturing fees from Bayer Health Care, Grants from Daiichi Sankyo Europe, consulting fees from Astra Zeneca, consulting fees and non-financial support from Diasorin and non-financial support from I.E.M., outside the submitted work. S.O.T has received lecture fees for Philips AG outside the submitted work. All other authors declare no disclosures that could be perceived as conflict of interest in the context of the present work.